CCRN
Cross Country Healthcare, Inc. NASDAQ$10.31
Mkt Cap $333.2M
52w Low $7.43
38.1% of range
52w High $14.99
50d MA $9.55
200d MA $10.85
P/E (TTM)
-3.5x
EV/EBITDA
11.7x
P/B
1.0x
Debt/Equity
0.0x
ROE
-25.7%
P/FCF
6.5x
RSI (14)
—
ATR (14)
—
Beta
0.34
50d MA
$9.55
200d MA
$10.85
Avg Volume
467.5K
About
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allie…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | 0.03 | -0.06 | -300.0% | 9.13 | -2.0% | +8.3% | +7.6% | +10.2% | +7.9% | +7.1% | — |
| Nov 12, 2025 | AMC | 0.04 | 0.03 | -25.0% | 12.65 | -13.4% | -14.1% | -12.0% | -8.0% | -7.2% | -8.8% | — |
| Aug 6, 2025 | AMC | 0.07 | -0.01 | -114.3% | 13.10 | -2.7% | -4.4% | -2.9% | -3.3% | -2.6% | +0.1% | — |
| May 7, 2025 | AMC | 0.04 | 0.06 | +50.0% | 13.84 | -2.5% | +0.4% | +1.2% | +0.6% | +0.8% | +1.1% | — |
| Mar 5, 2025 | AMC | 0.11 | 0.04 | -63.6% | 16.86 | -0.3% | -6.3% | -5.5% | -6.0% | -6.0% | -5.8% | — |
| Nov 6, 2024 | AMC | 0.10 | 0.12 | +20.0% | 12.15 | +0.2% | +1.0% | -14.7% | -11.5% | -9.2% | -16.9% | — |
| Jul 31, 2024 | AMC | 0.14 | 0.10 | -28.6% | 18.24 | -5.0% | -3.8% | -6.2% | -9.2% | -8.9% | -13.7% | — |
| May 1, 2024 | AMC | 0.17 | 0.19 | +11.8% | 17.90 | -9.9% | -6.5% | -6.9% | -10.5% | -8.2% | -8.0% | — |
| Feb 21, 2024 | AMC | 0.27 | 0.29 | +7.4% | 17.02 | -4.4% | -0.2% | -0.1% | +2.3% | +7.2% | +9.9% | — |
| Nov 1, 2023 | AMC | 0.41 | 0.39 | -4.9% | 23.09 | -30.2% | -13.8% | -16.1% | -18.7% | -20.2% | -19.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 | Wedbush | Upgrade | Neutral → Outperform | — | $8.86 | $9.31 | +5.1% | +5.5% | +3.6% | +8.0% | +10.0% | +10.5% |
| Mar 5 | Benchmark | Upgrade | Hold → Buy | — | $9.13 | $8.95 | -2.0% | +8.3% | +7.6% | +10.2% | +7.9% | +7.1% |
| Dec 9 | UBS | Maintains | Neutral → Neutral | — | $8.14 | $8.17 | +0.4% | -2.3% | +0.2% | +5.8% | +4.3% | +1.4% |
| Jun 17 | Barrington Research | Maintains | Market Perform → Market Perform | — | $13.79 | $13.68 | -0.8% | +1.2% | +3.3% | +1.7% | -3.6% | -4.6% |
| May 13 | UBS | Maintains | Neutral → Neutral | — | $13.92 | $13.92 | +0.0% | +0.2% | +0.5% | +0.2% | +0.5% | +0.1% |
| Mar 14 | Barrington Research | Maintains | Market Perform → Market Perform | — | $15.76 | $15.78 | +0.1% | -1.1% | -2.8% | -5.5% | -5.2% | -6.1% |
| Feb 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $18.22 | $18.21 | -0.1% | -0.1% | -0.2% | -0.1% | +0.1% | +0.1% |
| Dec 10 | Barrington Research | Downgrade | Outperform → Market Perform | — | $18.06 | $18.06 | +0.0% | +0.1% | -0.1% | +0.0% | +0.0% | -0.7% |
| Dec 5 | Truist | Maintains | Hold → Hold | — | $18.16 | $18.15 | -0.1% | -0.5% | -0.4% | -0.6% | -0.5% | -0.7% |
| Nov 7 | Benchmark | Maintains | Buy → Buy | — | $12.15 | $12.18 | +0.2% | +1.0% | -14.7% | -11.5% | -9.2% | -16.9% |
Recent Filings
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on April 17, 2026, disclosing material information to investors under Regulation FD guidelines.
Apr 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CCRN's departure of an executive officer removes potential relationship conflicts but raises questions about leadership stability and operational continuity that investors should monitor.
Mar 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The company's technology officer departure signals potential instability in critical infrastructure management, which could delay digital initiatives and warrant scrutiny of replacement candidate qualifications.
Mar 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Leadership transition effective March 10, 2026 could signal strategic direction changes or internal instability, making stock performance dependent on successor credibility and market confidence in continuity.
Mar 10
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare disclosed material information to investors under Regulation FD, ensuring equal access to non-public details across all shareholders simultaneously.
Mar 4
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 23, 2026, with details available in the filing exhibit, though the specific announcement content requires reviewing the attached materials for investment impact assessment.
Feb 23
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 12, 2026, disclosing material information to investors through regulatory filing.
Feb 12
Data updated apr 25, 2026 12:25am
· Source: massive.com